Kalimuddin, Shirin <br/><br/>
A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.  [electronic resource] 

 -  Trials  Jun 2018 
 - 305 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1745-6215 
<br/><br/><label>Standard No.: </label>10.1186/s13063-018-2702-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anti-Bacterial Agents--administration & dosage<br/>Bacteremia--diagnosis<br/>Cause of Death<br/>Daptomycin--administration & dosage<br/>Drug Resistance, Bacterial<br/>Early Termination of Clinical Trials<br/>Female<br/>Humans<br/>Male<br/>Methicillin-Resistant Staphylococcus aureus--drug effects<br/>Microbial Sensitivity Tests<br/>Middle Aged<br/>Predictive Value of Tests<br/>Recurrence<br/>Singapore<br/>Staphylococcal Infections--diagnosis<br/>Time Factors<br/>Treatment Outcome<br/>Vancomycin--administration & dosage